Research On Audit Risk Prevention Of R&D In Medical Equipment Listed Enterprises

With the rapid improvement of the material level,people’s medical needs have been greatly improved.The promotion of the national tiered medical services policy has also opened up the demand for primary medical care in China,followed by the huge market of medical equipment products.However,China’s medical device industry started late,and the overall technical level is relatively weak.High tech products are still dominated by foreign brand.China’s medical equipment enterprises are mainly small and medium-sized,and the head enterprises are far behind the leading foreign medical equipment enterprises.In order to promote the development of the industry and reduce the constraints caused by technology,China’s 13 th five year plan takes a new system of medical equipment industry as one of the policy priorities,and issues a series of policies such as priority approval,to encourage the medical equipment industry to replace imported products.To achieve the development and breakthrough of medical equipment industry,we need to invest a lot in R&D activities.R&D activities are more uncertain and risky than other activities due to complexity.The interdisciplinary and knowledge-intensive of medical device industry increase the complexity and uncertainty.On the one hand,enterprises may use this complexity to make up or overestimate R&D expenses in order to obtain benefits such as high-tech recognition,tax preference and R&D subsidy.On the other hand,the complicated accounting treatment of R&D expenditure and the broad rules such as the capitalization treatment also make the enterprises have more maneuverable space and bring risks to the authenticity of information disclosure.In addition,R&D is very important for the future development direction of medical equipment enterprises.Accidents in R&D activities may make the investment of the company go down the drain,even affect the capital flow of the enterprise.Based on this,this paper studies the audit risk of the R&D business of listed medical equipment enterprises,analyzes the risks in the R&D business accounting and business itself,constructs the corresponding major misstatement risk index system,in order to provide ideas for the audit of the R&D business of medical equipment.Based on the literature review of audit risk,R&D business and R&D expenditure capitalization,this paper takes listed medical equipment enterprises in China as the research object.Firstly,it introduces the R&D investment of medical equipment enterprises in China,and analyzes their R&D disclosure.Then on this basis,combined with the advice of experts,this paper summarizes the issues that need to be paid attention to in the audit of the R&D business of medical equipment enterprises.Then,the audit risk model is used as the framework to analyze the audit risk at different levels,and the factors that affect the risk of major misstatement in the analysis are formed into the corresponding index system.The Fuzzy Analytic Hierarchy Process and Particle Swarm Optimization are used to determine its weight,and take this as the framework to analyze the risk of major misstatement of R&D business of Improve Medical,and determine the risk level of major misstatement at all levels through expert scoring method and Fuzzy Comprehensive Evaluation.Finally,according to the above analysis of audit risk,the author puts forward relevant policy recommendations.